Written in

straightforward but warm language, "Muscular

Dystrophy in Children" defines the medical options,

offers guidance on parenting issues, discusses the

child's needs at different ages and describes the latest

research in muscular dystrophy. It carries a foreword by

Robert Ross, MDA senior vice president and executive

director.

Siegel is a

prolific physician-author. Some of his previous works are

for a general audience, while others are for medical

professionals. Among his books are "The Clinical

Management of Muscle Disease," "Muscle and Its

Diseases," "First Aid Without Fear" (first

aid for the blind in Braille), "Posture in the

Blind," "The Clinical I," "One

Wonderful Day at a Time" (for children), "Now

and At Other Times" (poetry), "101 Questions

and Answers About Muscular Dystrophy," "Hey,

I'm Here Too!" (for siblings of children with

muscular dystrophy), "101 Hints to Help-With-Ease

for Patients With Neuromuscular Disease," and

"All About Bone - An Owner's Manual."

MDA is a

voluntary health agency working to defeat 40

neuromuscular diseases through programs of worldwide

research, comprehensive patient and community services,

and far-reaching professional and public health

education. Recognized by the American Medical Association

with a Lifetime Achievement Award "for significant

and lasting contributions to the health and welfare of

humanity," MDA maintains 230 hospital-affiliated

clinics that offer families the best in care for

progressive neuromuscular diseases.

MDA

annually funds some 400 scientific teams worldwide. These

investigators have made significant advances toward cures

for several muscle-wasting diseases. They've pioneered

breakthroughs that may well lead to therapies for heart

disease, cancer, AIDS, Alzheimer's, Parkinson's,

Huntington's, and cystic fibrosis.

For

information about MDA research progress and/or referrals

to MDA clinics, call 1-800-572-1717, or visit MDA's Web

site at www.mdausa.org. MDA programs are almost entirely

funded by individual private contributors.